SCHEMBL2492034

SCHEMBL2492034

C=CCOC(=O)c1cncc2[nH]c3ccccc3c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.51
▸ KDM4E B2RXH2 5/20 0.48
▸ HSD17B10 Q99714 3/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 1/20 0.46
▸ GABRP O00591 4/20 0.42
▸ GABRD O14764 4/20 0.42
▸ GABRA1 P14867 4/20 0.42
▸ GABRB1 P18505 4/20 0.42
▸ GABRG2 P18507 4/20 0.42
▸ GABRB3 P28472 4/20 0.42
▸ GABRA5 P31644 4/20 0.42
▸ GABRA3 P34903 4/20 0.42
▸ GABRA2 P47869 4/20 0.42
▸ GABRB2 P47870 4/20 0.42
▸ GABRA4 P48169 4/20 0.42
▸ GABRE P78334 4/20 0.42
▸ GABRA6 Q16445 4/20 0.42
▸ GABRG1 Q8N1C3 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10642534 0.84 GABRP (0.58) KDM4EALDH1A1TSHRGABRPGABRD
Hydrochloric Acid SCHEMBL10641678 0.82 GABRP (0.57) KDM4EALDH1A1TSHRGABRPGABRD
SCHEMBL10644635 0.81 KDM4E (0.58) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL27763175 0.81 ALDH1A1 (0.47) CYP3A4MAPK1ALDH1A1TSHRGABRP
SCHEMBL10644994 0.77 PBRM1 (0.46) KDM4EALDH1A1GABRPGABRDGABRA1
SCHEMBL10642551 0.76 PARP1 (0.49) KDM4EHSD17B10MAPK1ALDH1A1GABRP
SCHEMBL8209973 0.73 GABRA1 (0.72) CYP3A4KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL3265121 0.72 CYP3A4 (0.61) CYP3A4HSD17B10ALDH1A1TSHRMEN1
SCHEMBL30388638 0.72 CYP3A4 (0.61) CYP3A4HSD17B10ALDH1A1TSHRMEN1
SCHEMBL17386427 0.72 CYP3A4 (0.76) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177621-B1 NOVEL HDAC6 INHIBITORS AND THEIR USES UNIV REGENSBURG (DE) 2021-11-10 — — EP disclosed
US-10106540-B2 HDAC6 inhibitors and their uses UNIVERSITÄT REGENSBURG (DE) 2018-10-23 — — US disclosed
US-20170210743-A1 NOVEL HDAC6 INHIBITORS AND THEIR USES Universitätsklinikum Jena (DE) 2017-07-27 — — US disclosed
EP-2550063-A1 ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE Council of Scientific & Industrial Research (IN) 2013-01-30 — — EP disclosed
US-20120245357-A1 ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-09-27 — — US disclosed
WO-2011117706-A1 ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2011-09-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210743-A1 NOVEL HDAC6 INHIBITORS AND THEIR USES HDAC6, HDAC5, HDAC4 CYP3A4 4529/4885KDM4E 676/4885HSD17B10 456/4885
US-10106540-B2 HDAC6 inhibitors and their uses HDAC6, HDAC5, HDAC4 CYP3A4 4365/4885KDM4E 608/4885HSD17B10 472/4885
US-20120245357-A1 ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE INSRR, AGTR2, ERG28 CYP3A4 4240/4885KDM4E 3864/4885HSD17B10 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback